Pillar 1 - FTO (new thread), page-1442

Hey buddy. This is not on my list because it did not clearly show that FTO was driving tumorigenesis in these cancer cells.

Yes, @IndexInvestor, I have that paper already.

There was this paper released yesterday (below), which increased the total number of articles supporting FTO as a driver of cancer to 80.

https://link.springer.com/article/10.1186/s12935-021-02146-w



What the TA people cannot interpret is just how close RAC are to generating the data necessary to determine the potential scale of a transaction. If the data is very positive and drives competition between big pharma players, I doubt even the most experienced TA expert could determine what the RAC SP will do.